The role of prevention in oncology practice: Results from a 2004 survey of American Society of Clinical Oncology members
The role of prevention in oncology practice: Results from a 2004 survey of American Society of Clinical Oncology members
复制标题
DOI：
10.1200/jco.2006.05.8321
复制
发表时间：
2006-06-20
影响因子：
45.3
通讯作者：
Lippman, SM
中科院分区：
文献类型：
--
作者：
Ganz, PA;Kwan, L;Lippman, SM
目的 2004 年，美国临床肿瘤学会 (ASCO) 癌症预防委员会对会员进行了调查，以描述其参与临床预防活动的情况。 方法 将先前进行的调查（包含有关遗传学、化学预防和生存率的最新项目）邮寄给 2,000 名国内会员的分层随机样本和 3,144 名国际会员的便利样本。结果 总共有 49.7% 的国内会员联系并符合调查条件进行了回复（n = 851）。无反应者更年轻（50.5 岁 vs 51.7 岁；P < .01）； 465 名国际会员作出回应。总体而言，35% 的人接受过癌症预防和控制方面的正式指导，大多数受访者预计在未来 5 年内会在其实践中更多地使用预防、筛查/早期检测以及降低风险/遗传咨询。大多数人报告说照顾癌症幸存者，包括提供一般医疗护理。他们还直接为患者提供或转介癌症预防和控制服务（例如癌症筛查、烟草和营养咨询、降低风险和化学预防）。多变量模型发现，在学术环境中执业、没有癌症诊断的患者比例较高、接受过预防和控制方面的正式培训、预计未来 5 年内预防活动会增加以及提供社区预防建议的人员中，将癌症预防活动纳入临床实践的感知障碍较少。 结论 将癌症预防和控制活动纳入肿瘤学临床实践的障碍存在。尽管如此，相当一部分国内和国际 ASCO 成员表示对癌症预防和控制活动感兴趣，希望在这一新兴的肿瘤学实践领域开展更具体的教育计划。
Purpose In 2004, the American Society of Clinical Oncology (ASCO) Cancer Prevention Committee surveyed the members to describe involvement in clinical prevention activities.Methods A previously administered survey, with updated items on genetics, chemoprevention, and survivorship, was mailed to a stratified random sample of 2,000 domestic members and a convenience sample of 3,144 international members.Results A total of 49.7% of domestic members contacted and survey eligible responded (n = 851). Nonresponders were younger (50.5 v 51.7 years; P < .01); 465 international members responded. Overall, 35% had received formal instruction in cancer prevention and control, and most respondents expected increased use of prevention, screening/early detection, and risk reduction/genetic counseling in their practices in the next 5 years. Most reported caring for cancer survivors, including providing general medical care. They also either directly provide or refer patients for cancer prevention and control services (eg, cancer screening, tobacco and nutrition counseling, risk reduction, and chemoprevention). Multivariable modeling found fewer perceived barriers to inclusion of cancer prevention activities in clinical practice among those practicing in an academic setting, seeing a higher proportion of patients without a cancer diagnosis, having formal training in prevention and control, expecting an increase in prevention activities in the next 5 years, and providing community advice on prevention.Conclusion Barriers to the inclusion of cancer prevention and control activities in oncology clinical practice exist. Nevertheless, a substantial proportion of both domestic and international ASCO members report an interest in cancer prevention and control activities, with a desire for more specific educational programs in this emerging area of oncology practice.